Skip to main content

Table 1 Subject demographics and BAL cell counts

From: Sarcoidosis activates diverse transcriptional programs in bronchoalveolar lavage cells

Subject

Gender

Age

Race

Smoking

Stage

Mac (%)

Lymph (%)

Pmn (%)

Eos (%)

Sarc 1

M

52

AA

Former

3

68

32

0

0

Sarc 2

F

32

AA

Former

3

67

30

3

0

Sarc 3

F

39

AA

Never

2

89

10

1

0

Sarc 4

F

61

AA

Never

NA

64

35

1

0

Sarc 5

M

57

AA

Former

3

95

4

0

1

Sarc 6

M

68

AA

Never

4

86

14

0

0

Sarc 7

F

62

AA

Never

0

53

47

0

0

Sarc 8

M

34

AA

Never

2

91

8

1

0

Sarc 9

F

47

AA

Former

4

97

3

0

0

Sarc 10

M

48

AA

Never

2

61

37

2

0

Sarc 11

F

53

C

Never

2

96

4

0

0

Sarc 12

F

39

AA

Never

2

70

30

0

0

Sarc 13

F

42

AA

Former

1

85

15

0

0

Sarc 14

F

46

AA

Never

2

67

9

24

0

Sarc 15

M

49

AA

Former

2

94

5

0

1

Cont 1

M

27

AA

Never

—

92

5

3

0

Cont 2

M

28

AA

Never

—

98

2

0

0

Cont 3

F

51

C

Never

—

92

8

0

0

Cont 4

F

31

AA

Never

—

92

8

0

0

Cont 5

F

26

AA

Never

—

91

4

3

2

Cont 6

F

24

AA

Never

—

95

5

0

0

Cont 7

F

28

AA

Never

—

98

1

0

1

Cont 8

M

28

C

Never

—

98

2

0

0

Cont 9

F

26

AA

Never

—

98

2

0

0

Cont 10

F

27

AA

Never

—

97

3

0

0

Cont 11

M

30

AA

Never

—

95

5

0

0

Cont 12

F

35

AA

Never

—

93

7

0

0

  1. Sarc sarcoidosis patient, Cont control subject, AA African American, C Caucasian, Mac macrophage, Lymph lymphocyte, Pmn polymorphonuclear cell, Eos eosinophil